Edward L. Korn

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Changing standard of care during a randomized trial: examples, considerations and guidelines

  JNCI Journal of the National Cancer Institute · 2026-01-18

• Outcome-Adaptive Randomization

  2025-12-01

• Intermediate and Surrogate Endpoints in Phase III Randomized Clinical Trials

  2025-12-01

• Role of Overall Survival in Cancer Treatment Approval: Comment on “Monitoring Overall Survival in Pivotal Trials in Indolent Cancers”

  Statistics in Biopharmaceutical Research · 2025-04-03 · 3 citations

• Non-inferiority trials: tyranny or good governance?

  The Lancet Oncology · 2025-01-01 · 1 citations

• Accrual Suspensions in Seamless Phase II/III Trials: A Review of NRG Oncology Trials

  JCO oncology advances. · 2024-12-01

• Phase III Evaluation of Treatment Combinations in Three-Arm Trials

  Journal of Clinical Oncology · 2024-10-28 · 3 citations

• 468 (PB456): Backfilling Patients in Phase I Dose Escalation Trials: Do it Safely and Efficiently

  European Journal of Cancer · 2024-10-01

• Two-to-One Randomization: Rarely Advisable

  JCO Oncology Practice · 2024-07-11 · 5 citations